Please see this month's publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
Brookline Capital Markets
投资银行业务
New York，New York 1,591 位关注者
Providing a comprehensive suite of capital markets and advisory services to cutting-edge healthcare companies
关于我们
Brookline Capital Markets, a division of Arcadia Securities, LLC, provides a comprehensive suite of capital markets and advisory services to cutting-edge public and private emerging growth companies. Brookline seeks opportunities to accelerate growth for its client companies while delivering results to the firm’s sophisticated investor base. Brookline has significant experience providing the following services: Pre-IPO Financings IPOs, Secondaries and PIPEs Trade Facilitation for Private Equities Capital Markets Advisory Strategic Advisory Equity Research Brookline differentiates itself through its ability to source capital from traditional institutional investors, as well as from its proprietary network of global family office and high net worth individual investors. For many of the firm’s family office and high net worth clients, Brookline serves as a “curator” of compelling early stage venture and growth equity opportunities. This investor base provides companies access to patient and sophisticated capital. In addition to Brookline’s unique, non-institutional investor network in the U.S., the firm maintains a significant presence internationally. Investors in recent transactions include funds and wealthy individuals located in Canada, China, Hong Kong, Italy, Korea, and the U.K. Brookline is led by seasoned investment banking professionals, each with more than 25 years of capital markets and advisory experience at some of the world’s most prominent financial institutions.
- 网站
-
https://www.brooklinecapmkts.com
Brookline Capital Markets的外部链接
- 所属行业
- 投资银行业务
- 规模
- 11-50 人
- 总部
- New York，New York
- 类型
- 私人持股
- 领域
- Advisory和Investment Banking
地点
-
主要
获取路线
280 Park Avenue.
Floor 43W
US，New York，New York，10017
Brookline Capital Markets员工
动态
-
Please see this month's publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
-
Please see this month's publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
-
Please see this month's publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
-
Please see our monthly publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
-
The Brookline Team is pleased to share with you the news of OS Therapies Inc.’s (NYSEAMEX: OSTX) $6,400,000 IPO, which priced on July 31st, 2024. Brookline Capital Markets, a division of Arcadia Securities, LLC, served as the sole bookrunner for the transaction. In addition, please see our monthly publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
-
OS Therapies (OSTX) Announces Pricing of its Initial Public Offering on NYSE American. Brookline Capital Markets, a division of Arcadia Securities, LLC?acted as the sole bookrunner for the offering. ? Full Press Release:??https://lnkd.in/g8xuxhFC Michael Fontaine #Brookline #investmentbanking #capitalmarkets #NYSE #NYSEAmerican #OSTherapies $OSTX
-
-
Please see our monthly publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.
-
Please see our monthly publication of The Brookline Brief below, which describes the current state of the life sciences-, med. tech.-, and diagnostics-focused subsegments of the Equity Capital Markets along with a summary below of the key recent new issue market and/or broader equity market developments that have materialized over the course of the past several weeks.